Defining On-Treatment Remission in Plaque Psoriasis

Overview of attention for article published in JAMA Dermatology, August 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 5 news outlets
twitter: 6 X users
video: 1 YouTube creator

bluesky: 2 Bluesky users
podcasts: 3 podcasts

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 36,135 followers.

This Consensus Statement from @NPF defines on-treatment remission for plaque psoriasis as maintaining 0% body surface involvement or an Investigator Global Assessment score of 0 for at least six months during therapy. https://t.co/fK2B6vkIpr @DrJoelGelf…

Consensus from the National Psoriasis Foundation defines on-treatment remission in plaque psoriasis to improve patient therapy alignment. PMID:40531503, JAMA Dermatol 2025 https://t.co/Pi8DzODqlN #AI #Pharma #BioMed #RNA #ASHG #ESHG

RT @Dermoutcomes: New @JAMADerm consensus: On-treatment remission in plaque #psoriasis = BSA 0% or IGA 0 for ≥6 mos on therapy. Authored b…

New @JAMADerm consensus: On-treatment remission in plaque #psoriasis = BSA 0% or IGA 0 for ≥6 mos on therapy. Authored by 90+ experts incl. @JosephMerolaMD , Dr @_AprilArmstrong & Dr. Pérez-Chada. 🔗 https://t.co/B8OPkWZzPG #DermTwitter https://t.…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.